Back to Trades
Lubner David Charles
DirectorCIK 0001572000
Total Volume
$6.5M
8 filings
Purchases
$1000.0K
1 buy txns
Sales
$450.0K
1 sell txns
Net Activity
$550.0K
net bought
Profile
- Filings
- 8
- Buy transactions
- 1
- Sell transactions
- 1
- Companies
- 5
- Active
- 2025–2026
Lubner David Charles, Director, accounts for 8 disclosed filings worth $6.5M, spread across 5 companies, active 2025–2026. The record is net buying, with $1000.0K in purchases against $450.0K in sales. The largest single open-market purchase on record is $1000.0K in Braveheart Bio, Inc.. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
8 loaded
| Aug 7 | BRVE Braveheart Bio, Inc. | Lubner David Charles | Director | Buy | $1000.0K |
| Aug 5 | BRVE Braveheart Bio, Inc. | Lubner David Charles | Director | Other | $0 |
| Jun 9 | DYN Dyne Therapeutics, Inc. | Lubner David Charles | Insider | Award | $599.0K |
| Jun 3 | CBIO CRESCENT BIOPHARMA, INC. | Lubner David Charles | Director | Award | $188.0K |
| Apr 28 | DYN Dyne Therapeutics, Inc. | Lubner David Charles | Insider | Gift | $0 |
| Apr 28 | ACLX Arcellx, Inc. | Lubner David Charles | Insider | Disposed | $3.0M |
| Jan 20 | ACLX Arcellx, Inc. | Lubner David Charles | Insider | Sell | $450.0K |
| Aug 19 | CRGX CARGO Therapeutics, Inc. | Lubner David Charles | Insider | Disposed | $108.8K |
8 filings